FDA staff endorses J&J’s single-shot COVID-19 vaccine for emergency
February 25, 2021: The Food and Drug Administration’s staff approved Johnson & Johnson’s Covid-19 vaccine for emergency use, a crucial step that brings the third shot to the U.S. marketplace.
